title: The role of nuclear morphometry for predicting disease outcome in patients with localized renal cell carcinoma.
abstract: BACKGROUND
  More than one-third of patients with localized renal cell carcinoma (RCC) will have disease progression after nephrectomy. Present histopathologic variables cannot accurately predict the outcome of individual patients.
  
  
  METHODS
  Nuclear morphometry was performed by an image analyzer on histologic sections from 39 specimens of pathologic T1 and T2 classification RCC. All patients underwent radical nephrectomy and were followed for a mean of 7.6 years. A univariate analysis and then a multivariate stepwise regression method were used to correlate results with patients' outcome.
  
  
  RESULTS
  The best predictors of disease free interval were mean nuclear elongation factor (MNEF) (P = 0.023), mean nuclear regularity factor (MNRF) (P = 0.034), and mean nuclear area (MNA) (N = 0.038). Univariate analysis identified a significant correlation between patient survival and MNEF (P = 0.009), MNRF (P = 0.020) and MNA (P = 0.023). Combination of MNEF and MNA was even more strongly associated with survival (P = 0.0013). Multivariate analysis revealed that MNA (P = 0.044) and MNEF (P = 0.045) correlated independently with survival.
  
  
  CONCLUSIONS
  These results suggest that nuclear morphometry provides objective independent prognostic information for patients with localized RCC.
authors.affiliation: Department of Urology, Bnai Zion Medical Center, Haifa, Israel.
authors.forename: O
authors.initials: O
authors.lastname: Nativ
authors.forename: E
authors.initials: E
authors.lastname: Sabo
authors.forename: G
authors.initials: G
authors.lastname: Raviv
authors.forename: O
authors.initials: O
authors.lastname: Medalia
authors.forename: B
authors.initials: B
authors.lastname: Moskovitz
authors.forename: B
authors.initials: B
authors.lastname: Goldwasser
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D002292:Carcinoma, Renal Cell / Q000473:pathology* / Q000601:surgery; D018450:Disease Progression; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D012189:Retrospective Studies; D016019:Survival Analysis